Invesco Global Health Sciences Fund is an open-end unit trust established in Taiwan. The Fund's objective is to generate long-term capital growth. The Fund invests primarily in equities of companies throughout the world in the health sciences industr...Show all
Phone: 886-2-2719-7890
8F, No. 122, Tung Hua N. Road
Taipei,
Taiwan
Date | Company | Round | Amount | Co-investors |
---|---|---|---|---|
2001-12-26 | Syrrx | Series D | $18.5M | Alejandro Zaffaroni, Bay City Capital, Canadian Imperial Bank of Commerce, CMEA Capital, Cooper Hill Partners, HBM Partners, Jaspers, Joe Lewis, Lombard Odier, MPM Capital, Versant Ventures, and Wanger Asset Management |
2001-01-01 | Syrrx | Series C | $54M | Alejandro Zaffaroni, Bay City Capital, Canadian Imperial Bank of Commerce, CMEA Capital, Cooper Hill Partners, Jaspers, Joe Lewis, Lombard Odier, MPM Capital, Novartis Venture Funds, Versant Ventures, and Wanger Asset Management |